Russian Direct Investment Fund
- All
- News
- Videos
-
Russia May Launch Sputnik Light Covid Vaccine In India By Next Month
The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
-
Morepen Labs In Himachal Starts Production Of Test Batch Of Sputnik V Vaccine
Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday.
-
Sputnik V To Offer Booster Shots Against Delta Variant To Other Vaccine Makers
The Russian Direct Investment Fund today said its Covid vaccine Sputnik V will soon offer a booster shot or the second dose of the vaccine, which has been adjusted to work against the Delta variant of coronavirus, to other vaccine manufacturers.
-
Sputnik Light Covid Vaccine Shows 78.6-83.7% Efficacy Among Elderly: Russian Maker
The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
Mumbai Gets 3 Bids From Russia's Sputnik Covid Vaccine Makers
The London-based facilitator of the Russian Direct Investment Fund and its India-based independent representatives have together made three bids for the supply of one crore Sputnik V Covid vaccine doses to the Mumbai civic body.
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Sputnik More Effective Against Mutations, Says Russian Maker. Here's Why
Russia's Sputnik V, the third Covid vaccine to be cleared for use in India, is effective against mutant strains, the Russian Direct Investment Fund (RDIF) has said.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
-
Russia May Launch Sputnik Light Covid Vaccine In India By Next Month
The Russian Direct Investment Fund today informed that Sputnik light COVID-19 vaccine will likely be launched in India by December this year.
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
-
Morepen Labs In Himachal Starts Production Of Test Batch Of Sputnik V Vaccine
Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, Russian Direct Investment Fund (RDIF) and the domestic drug firm said in a statement on Tuesday.
-
Sputnik V To Offer Booster Shots Against Delta Variant To Other Vaccine Makers
The Russian Direct Investment Fund today said its Covid vaccine Sputnik V will soon offer a booster shot or the second dose of the vaccine, which has been adjusted to work against the Delta variant of coronavirus, to other vaccine manufacturers.
-
Sputnik Light Covid Vaccine Shows 78.6-83.7% Efficacy Among Elderly: Russian Maker
The Russian Direct Investment Fund (RDIF) on Wednesday announced that the Russian Sputnik Light coronavirus vaccine demonstrates 78.6-83.7 per cent efficacy among the elderly.
-
COVID-19 Vaccine Sputnik V Production Launched In India
Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund has begun the production of Sputnik V COVID-19 vaccine in India, according to a joint statement issued today.
-
Mumbai Gets 3 Bids From Russia's Sputnik Covid Vaccine Makers
The London-based facilitator of the Russian Direct Investment Fund and its India-based independent representatives have together made three bids for the supply of one crore Sputnik V Covid vaccine doses to the Mumbai civic body.
-
1st Lot Of Russian COVID-19 Vaccine Sputnik V Likely In India By May End
Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, today said it expects the first lot of stock from Russian Direct Investment Fund by May end.
-
Sputnik More Effective Against Mutations, Says Russian Maker. Here's Why
Russia's Sputnik V, the third Covid vaccine to be cleared for use in India, is effective against mutant strains, the Russian Direct Investment Fund (RDIF) has said.
-
India's Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Yearly: Report
Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
